Tower Research Capital (TRC)’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$127K Buy
3,295
+3,271
+13,629% +$136K ﹤0.01% 1992
2025
Q4
$1.11K Sell
24
-431
-95% -$20.8K ﹤0.01% 4758
2025
Q3
$22.3K Buy
455
+354
+350% +$18.5K ﹤0.01% 3219
2025
Q2
$5.23K Buy
+101
New +$4.08K ﹤0.01% 4212

Other funds holding HNGE

Tower Research Capital (TRC)'s HNGE Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Hinge Health (HNGE) stake by 13,629% in Q1 2026, buying an estimated $136K and bringing the position to 3,295 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #1992.

Tower Research Capital (TRC) first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Tower Research Capital (TRC) held 3,295 shares of Hinge Health worth $127K as of Q1 2026.
  • Tower Research Capital (TRC) bought 3,271 Hinge Health shares in Q1 2026, an estimated $136K.
  • Hinge Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1992 holding.
  • Tower Research Capital (TRC) first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.